REFERENCES
  1. Jemilohun AC, Adewoye OG. liver cirrhosis from autoimmune hepatitis in a Nigerian woman: a case report. Ann Ibd. Pg. Med. 2017; 15 (2): 133-136.
  2. Chazouillère O. A case of auto-immune hepatitis. GastroenterolClin Biol 2009; 33: 36-43.
  3. Jemilohun AC, Ola TS. Autoimmune Liver Diseases in Native Black Africans: Extremely Rare or Inadequately Investigated Diseases?JAMMR. 2017; 24(7): 1-14.
  4. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Autoimmune hepatitis. J Hepatol. 2015; 63: 971-1004.
  5. Gleeson D, Heneghan MA. British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis. Gut . 2011 :1-19.
  6. Mack CL, Adams D, Assis DN, et al. Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines from the American Association for the Study of Liver Diseases. Hepatology . 2020; 0(0): 1-52.
  7. Corpechot C, Chazouillères O. autoimmune hepatitis: Diagnostic and therapeutic up-to-date. Rev Med int. 2010; 13: 606-14.
  8. Lemoinne S, Wendum D, Corpechot C, Chazouillères O. Hépatites auto-immunes : aspects diagnostiques et thérapeutiques. Hépato Gastro. 2016 ; 23 : 637-52. doi : 10.1684/hpg.2016.1323.
  9. Gournay J. L’hepatite auto-immune. Hépato Gastro. 2017; 24: 830-845. doi : 10.1684/hpg.2017.1521.
  10. Manns MP, Strassburg CP. Autoimmune hepatitis: clinical challenges.Gastroenterology. 2001; 120: 1502-17.
  11. Manns MP, Bahr MJ, Woynarowski M, et al. Budesonide 3 mg tid is superior to prednisone in combination with azathioprine in the treatment of autoimmune hepatitis. J Hepatol . 2008; 48: S369-70.
  12. Kanzler S, Gerken G, Löhr H, et al. Duration of immunosuppressive therapy in autoimmune hepatitis. J Hepatol . 2001; 34:354-5.
  13. Czaja AJ, Davis GL, Ludwig J, Taswell HF. Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis. Hepatology . 1984; 4: 622-7.